Arthur Caplan Discusses Issues Facing The Growing Field of Bioethics

Interview By:, Franklin Hoke and Karen Young Kreeger, pp.12 Date: October 17, 1994 In May 1994, preeminent bioethicist Arthur Caplan moved his base of operations from the University of Minnesota, Minneapolis, where he had established the Center for Biomedical Ethics, to the University of Pennsylvania in Philadelphia. There, he launched the Center for Bioethics, hoping to expand the purview of his activities through association with

Written byArthur Caplan
| 14 min read

Register for free to listen to this article
Listen with Speechify
0:00
14:00
Share

Interview By:, Franklin Hoke and Karen Young Kreeger, pp.12
Date: October 17, 1994

In May 1994, preeminent bioethicist Arthur Caplan moved his base of operations from the University of Minnesota, Minneapolis, where he had established the Center for Biomedical Ethics, to the University of Pennsylvania in Philadelphia. There, he launched the Center for Bioethics, hoping to expand the purview of his activities through association with the extensive biomedical research community at Penn and in the greater Philadelphia area-- initially, for example, sharing temporary offices with the university's Institute for Human Gene Therapy. The 44-year-old Caplan, who is the author of dozens of scholarly papers, also strives to make critical bioethical debates comprehensible to the public, most recently in his book Moral Matters: Ethical Issues in Medicine and the Life Sciences (New York, John Wiley & Sons Inc., 1995).

As the fall semester got under way at Penn last month, Caplan ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies